242 filings
8-K
INM
InMed Pharmaceuticals Inc
14 May 24
InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
4:12pm
10-Q
2024 Q3
INM
InMed Pharmaceuticals Inc
Quarterly report
13 May 24
6:27pm
8-K
INM
InMed Pharmaceuticals Inc
18 Apr 24
Regulation FD Disclosure
1:30pm
8-K
INM
InMed Pharmaceuticals Inc
16 Apr 24
InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration
2:39pm
8-K
INM
InMed Pharmaceuticals Inc
5 Apr 24
Regulation FD Disclosure
11:26am
8-K
74woachh0wdmy
20 Mar 24
InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance
1:44pm
8-K
r8zzttp3ntc0
13 Feb 24
InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update
7:34pm
8-K
y6utaojii76tp
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
8-K
gkymnkxnbvw
19 Jan 24
Regulation FD Disclosure
2:33pm
8-K
j86mf aqmaoj
16 Jan 24
InMed Pharmaceuticals Provides Business Update and Milestones for 2024
2:12pm
S-8
v4ifmomz2lgm4k7
21 Dec 23
Registration of securities for employees
7:22pm
8-K
kfgg fbztofk9z863
19 Dec 23
InMed Announces Results of 2023 Annual General Meeting
8:08pm
8-K
x3exarb
29 Nov 23
Regulation FD Disclosure
2:50pm
8-K
ge370jqer009
14 Nov 23
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
4:36pm
EFFECT
t6290
14 Nov 23
Notice of effectiveness
12:15am
424B3
jha0gl8
13 Nov 23
Prospectus supplement
5:05pm
UPLOAD
sz4s0 vdat0e6t9m
10 Nov 23
Letter from SEC
12:00am